drugset / Trial / NCT01313312
Dysport® Adult Upper Limb Spasticity Extension Study
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to assess the long term safety of Dysport® in hemiparetic subjects with upper limb spasticity due to stroke or traumatic brain injury over repeated treatment cycles.
Timeline
- Start
- 2011-11
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 500 iu | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 1000 iu | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 1500 iu | Intramuscular |